Literature DB >> 10613811

Multiple approaches to multiple sclerosis.

L Steinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10613811     DOI： 10.1038/71466

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

Review 1.  Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Authors:  Ludwig Kappos; Jens Kuhle; Achim Gass; Lutz Achtnichts; Ernst-Wilhelm Radue
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis.

Authors:  Hans-Peter Hartung; Bernd C Kieseier; Bernhard Hemmer
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 3.  Autophagy, inflammation and neurodegenerative disease.

Authors:  Mehrdad Alirezaei; Christopher C Kemball; J Lindsay Whitton
Journal:  Eur J Neurosci       Date:  2010-12-07       Impact factor: 3.386

4.  Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Patricia Gonnella; Farinaz Safavi; Ghazal Vessal; Bardia Nourbakhsh; Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-09-23       Impact factor: 3.478

5.  Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.

Authors:  P Villoslada; S L Hauser; I Bartke; J Unger; N Heald; D Rosenberg; S W Cheung; W C Mobley; S Fisher; C P Genain
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

6.  Dynamics of the meningeal CD4(+) T-cell repertoire are defined by the cervical lymph nodes and facilitate cognitive task performance in mice.

Authors:  A Radjavi; I Smirnov; N Derecki; J Kipnis
Journal:  Mol Psychiatry       Date:  2013-06-11       Impact factor: 15.992

7.  Spinal motoneurone distress during experimental allergic encephalomyelitis.

Authors:  L Giardino; A Giuliani; M Fernandez; L Calzà
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.